Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

MGT Capital Investments, Inc.’s Plan of Compliance Accepted by NYSE AMEX, LLC

August 29, 2011 By Bio-Medicine.Org

NEW YORK, Aug. 29, 2011 /PRNewswire/ — MGT Capital Investments,
Inc. (“MGT”, “we”, or “the Company”) (AMEX: MGT.BC), a holding
company engaged in the medical imaging industry, announced today
that NYSE Amex, LLC (the “Exchange”) has accepted the Company’s
plan of compliance (the “Plan”) submitted in response to a notice
from the Exchange Staff dated June 8, 2011 indicating that the
Company was not in compliance with certain continued listing
standards as set forth in Part 10 of the Exchange’s Company
Guide.

Specifically, the Exchange Staff noted that the Company was not
in compliance with: (a) Section 1003(a)(i) of the Company
Guide, resulting from stockholders’ equity on March 31, 2011 of
less than $2,000,000 and losses from continuing operations and/or
net losses in two of its three most recent fiscal years; (b)
Section 1003(a)(ii) of the Company Guide with stockholders’ equity
of less than $4,000,000 and losses from continuing operations
and/or net losses in three of its four most recent fiscal years;
and (c) Section 1003(a)(iii) with stockholders’ equity of less than
$6,000,000 and losses from continuing operations and/or net losses
in its five most recent fiscal years.  The Company was
afforded the opportunity to submit the Plan to the Exchange and on
July 15, 2011 presented the Plan to the Exchange.  

On August 23, 2011, the Exchange notified the Company that it
had accepted the Plan and granted the Company an extension until
December 8, 2012 to regain compliance with Sections 1003(a)
(i)-(iii) of the Company Guide.  The Company will be subject
to periodic review by Exchange Staff during the extension period.
 Failure to make progress consistent with the Plan or to
regain compliance with the continued listing standards by the end
of the extension period could result in the Exchange initiating
delisting proceedings pursuant to Section 1009 of the Company
Guide.

The Exchange further notified the Company that

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech